STUDIO

"We have increasing sales but still a lot of untapped potential”, says new CEO of PHI

“We show increasing sales but there is still a lot of...

PHI specializes in non-invasive cell analysis, enabling researchers to study cells without disrupting their natural state. The company’s products and technology are utilized by...

RECOMMENDED READING

Medivir to highlight promising clinical data at EASL

Medivir to highlight promising clinical data at EASL

Medivir will present final safety and efficacy data from its phase Ib/IIa liver cancer...
Lipum

Lipum’s CEO reflects on the year and comments on Eurostars funding

2024 was an eventful year for Lipum, setting the stage for an equally exciting...

EVENT